Arch Chemicals (ARJ) Swings to Q4 Loss; Guides Q1, FY09
Arch Chemicals, Inc. (NYSE: ARJ) reports Q4 loss of $0.75, versus the analyst estimate of ($0.01). Revenue for the quarter was $307.5 million, versus the consensus of $352.55 million.
Sees Q1 loss of $0.05-$0.15, versus the Street estimate of a gain of $0.15. .Sees FY09 sales up 2-4% and adj-EPS of $1.85-$2.05, versus the consensus of $2.07.
Sees Q1 loss of $0.05-$0.15, versus the Street estimate of a gain of $0.15. .Sees FY09 sales up 2-4% and adj-EPS of $1.85-$2.05, versus the consensus of $2.07.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Jiayuan.com (DATE) Reports In-Line Q1 EPS of 5c; Guides Q2 Revs
- ATA, Inc. (ATAI) Misses Q4 EPS by 1c; Guides FY13 Revs Below
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
